Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole IV + Ceftriaxone in Intra-abdominal Infection
NCT01473836Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metronidazole in Intra-abdominal infection (IAI), pelvic inflammatory disease (PID), sponsored by Pfizer. Started Nov 2011; status: completed.
02
Drugs
metronidazole
03
Conditions
Intra-abdominal infection (IAI)pelvic inflammatory disease (PID)
Beyond the preview
Go deeper on NCT01473836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01473836.